Detalles de la búsqueda
1.
A Randomized Placebo-Controlled Trial of the Anti-Nerve Growth Factor Antibody Tanezumab in Subjects With Cancer Pain Due to Bone Metastasis.
Oncologist
; 28(12): e1268-e1278, 2023 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37343145
2.
Characterization of adverse joint outcomes in patients with osteoarthritis treated with subcutaneous tanezumab.
Osteoarthritis Cartilage
; 31(12): 1612-1626, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37652258
3.
Patient characteristics, pain treatment patterns, and incidence of total joint replacement in a US population with osteoarthritis.
BMC Musculoskelet Disord
; 23(1): 883, 2022 Sep 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36151530
4.
The moral status of the fetus: Implications of the somatic integration definition of human life.
Bioethics
; 35(7): 672-679, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33529422
5.
Postoperative Outcome of Patients Who Underwent Total Joint Replacement During the Tanezumab Phase 3 Osteoarthritis Development Program: A 24-Week Observational Study.
Surg Technol Int
; 38: 467-477, 2021 05 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34043229
6.
Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period.
Ann Rheum Dis
; 79(6): 800-810, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32234715
7.
The somatic integration definition of the beginning of life.
Bioethics
; 33(9): 1035-1041, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31452225
8.
Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee: A Randomized Clinical Trial.
JAMA
; 322(1): 37-48, 2019 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31265100
9.
The Moral Status of the Human Embryo.
J Med Philos
; 43(2): 132-158, 2018 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-29546412
10.
Response to: 'Use of tanezumab for patients with hip and knee osteoarthritis with reference to a randomised clinical trial by Berenbaum and colleagues' by Riddle and Perera.
Ann Rheum Dis
; 81(4): e66, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32424029
11.
Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain.
Ann Rheum Dis
; 74(6): 1202-11, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24625625
12.
Exploring the role of tanezumab as a novel treatment for the relief of neuropathic pain.
Pain Med
; 16(6): 1163-76, 2015 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-25594611
13.
Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.
Ann Rheum Dis
; 73(9): 1665-72, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23852695
14.
Tanezumab reduces osteoarthritic hip pain: results of a randomized, double-blind, placebo-controlled phase III trial.
Arthritis Rheum
; 65(7): 1795-803, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23553790
15.
Effect size varies based on calculation method and may affect interpretation of treatment effect: an illustration using randomised clinical trials in osteoarthritis.
Adv Rheumatol
; 64(1): 31, 2024 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38650049
16.
Tanezumab for the treatment of pain from osteoarthritis of the knee.
N Engl J Med
; 363(16): 1521-31, 2010 Oct 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-20942668
17.
Peripheral Nerve Safety of Nerve Growth Factor Inhibition by Tanezumab: Pooled Analyses of Phase III Clinical Studies in Over 5000 Patients with Osteoarthritis.
Clin Drug Investig
; 43(7): 551-563, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37460782
18.
Predicting Treatment Responses in Patients With Osteoarthritis: Results From Two Phase III Tanezumab Randomized Clinical Trials.
Clin Pharmacol Ther
; 113(4): 878-886, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36621827
19.
Efficacy, General Safety, and Joint Safety of Tanezumab in Japanese Patients with Osteoarthritis: Subgroup Analyses from Two Randomized, Phase 3 Studies.
Pain Ther
; 11(3): 827-844, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35538185
20.
General Safety and Tolerability of Subcutaneous Tanezumab for Osteoarthritis: A Pooled Analysis of Three Randomized, Placebo-Controlled Trials.
Arthritis Care Res (Hoboken)
; 74(6): 918-928, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33973384